Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Ferrous Sulfate/Ascorbic Acid in Anemia: NCT07577817 Clinical Landscape Report 2026
15 October 2026
NCT07577817 clinical landscape for Anemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine Hydrochloride in Pancreatic carcinoma non-resectable: NCT07575191 Clinical Landscape Report 2026
15 October 2026
NCT07575191 clinical landscape for Pancreatic carcinoma non-resectable: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Retlirafusp alfa in Gonorrhea: NCT07581574 Clinical Landscape Report 2026
15 October 2026
NCT07581574 clinical landscape for Gonorrhea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Toripalimab in CLDN18.2 positive Gastroesophageal junction adenocarcinoma: NCT07584135 Clinical Landscape Report 2026
15 October 2026
NCT07584135 clinical landscape for CLDN18.2 positive Gastroesophageal junction adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context…
![[64Cu]Cu-AKY-2519 in Metastatic castration-resistant prostate cancer: NCT07581184 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_B_105_21748b7b06.jpg)
9 min read
[64Cu]Cu-AKY-2519 in Metastatic castration-resistant prostate cancer: NCT07581184 Clinical Landscape Report 2026
15 October 2026
NCT07581184 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Apomorphine Hydrochloride in Parkinson Disease: ACTRN12626000594325 Clinical Landscape Report 2026
15 October 2026
ACTRN12626000594325 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Metastatic Pancreatic Cancer: NCT07587827 Clinical Landscape Report 2026
15 October 2026
NCT07587827 clinical landscape for Metastatic Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YS-247 in Metastatic castration-resistant prostate cancer: NCT07583160 Clinical Landscape Report 2026
15 October 2026
NCT07583160 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
177Lu-SNA040 in Advanced Bile Duct Carcinoma: NCT07595237 Clinical Landscape Report 2026
15 October 2026
NCT07595237 clinical landscape for Advanced Bile Duct Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dupilumab in Pulmonary Disease, Chronic Obstructive: NCT07587658 Clinical Landscape Report 2026
15 October 2026
NCT07587658 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
IBI3028 in Locally Advanced Malignant Solid Neoplasm: NCT07589205 Clinical Landscape Report 2026
15 October 2026
NCT07589205 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
FPI-2265 in Metastatic Prostate Carcinoma: NCT07590934 Clinical Landscape Report 2026
15 October 2026
NCT07590934 clinical landscape for Metastatic Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.